| Size | 10 mg/50 mg |
| Purity | ≥98% |
| Formula | C23H20N4O3S3 |
| Molecule Mass | 496.62 |
| Chemical Name | N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-3-(2-methoxyphenyl)-4-oxothieno[3,2-d]pyrimidin-2-yl)thio]-acetamide |
| SMILES | O=C1C3=C(CCS3)N=C(SCC(NC4=NC(C=CC(C)=C5)=C5S4)=O)N1C2=C(OC)C=CC=C2 |
| Target | Wnt/β-catenin |
| Biological Activity | IWP 4 is a potent inhibitor of Wnt/β-catenin signaling (IC50 = 25 nM) with minimal effects on the Notch and Hedgehog pathways. It is primarily used to induce cardiomyocyte differentiation from human ESCs and iPSCs. |
| Appearance | Solid |
| Color | White to light yellow |
| Solubilization | The compound is soluble to 1 mM in DMSO |
| Storage | Store at +4°C |
| Shipping Information | Room temperature |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.